Can You Have Cushing Disease With a Normal Brain MRI?
At a Glance
A normal brain or pituitary MRI does not rule out Cushing disease because the ACTH-producing pituitary tumor can be only a few millimeters. Doctors confirm excess cortisol and ACTH dependence with hormone tests and may use specialized IPSS blood sampling to identify the source before treatment.
In this answer
4 sections
Yes, a person can have Cushing disease even if their brain or pituitary MRI is normal. Specialist reviews indicate that a substantial minority of patients with confirmed Cushing disease—up to 40% in some specialized centers—have no visible tumor on a standard clinical MRI [1].
Getting a “normal” scan when you are experiencing severe symptoms can be stressful and may lead to feelings of imposter syndrome. However, in the diagnosis of Cushing disease, a negative MRI is a known possibility, not a definitive rule-out [2].
Why Might the Tumor Be Invisible on an MRI?
Cushing disease is caused by a benign (non-cancerous) tumor in the pituitary gland that secretes excess ACTH (adrenocorticotropic hormone), which is a hormone that signals your adrenal glands to produce too much cortisol [3]. Although these tumors are benign, the excess cortisol they cause seriously affects blood pressure, blood sugar, mood, and muscle strength.
The vast majority of these tumors are microadenomas, meaning they are very small [4]. In Cushing disease, they can sometimes be just 1 to 2 millimeters in size [5].
Because of their tiny size, these tumors may not appear on standard imaging [1]. A routine brain MRI is typically not optimized to find a corticotroph microadenoma. Even with a dedicated dynamic contrast pituitary MRI on a high-resolution 3-Tesla (3T) scanner, the smallest tumors can blend in with healthy tissue and remain undetected [6].
The Diagnostic Pathway: Testing Hormones First
Because imaging cannot always find these small tumors, endocrinologists rely on a careful biochemical process to confirm the diagnosis before deciding on next steps:
- Confirming excess cortisol (hypercortisolism): Doctors use tests like 24-hour urinary free cortisol, late-night salivary cortisol, and dexamethasone suppression testing to verify that your body is producing an abnormal, excess amount of cortisol [7].
- Establishing ACTH-dependence: Next, doctors measure your blood ACTH levels. If your ACTH is high or unsuppressed (meaning the hormone level does not drop as it normally should), it indicates your condition is ACTH-dependent—meaning a tumor is actively driving the excess cortisol [3].
- Evaluating the source: An ACTH-dependent result does not automatically mean the tumor is in the pituitary gland. It could also come from an ectopic source (a tumor located elsewhere in the body, such as the lungs) [8].
Locating the Source: What is IPSS?
If your tests confirm ACTH-dependent hypercortisolism but your pituitary MRI is normal (or shows an uncertain spot smaller than 6 millimeters), an endocrinologist at a specialized center may recommend Inferior Petrosal Sinus Sampling (IPSS) [8].
IPSS is a highly accurate, specialized procedure used to help distinguish a pituitary source from an ectopic source [9].
During IPSS, an interventional radiologist carefully guides small catheters through a vein in the groin up to the inferior petrosal sinuses, which are the veins that drain blood directly from the pituitary gland [9]. The doctor measures the ACTH levels in the blood draining from the pituitary and compares them to the ACTH levels in your general bloodstream.
Samples are usually taken before and after administering a stimulating hormone, like CRH or desmopressin [8]. A central-to-peripheral ACTH ratio (comparing the pituitary-draining blood to the general circulating blood) of at least 2 before stimulation, or at least 3 after stimulation, strongly supports a pituitary source [8] [10].
Important considerations regarding IPSS:
- It is not definitive proof of a tumor’s exact location: While IPSS strongly supports a pituitary diagnosis, it is not infallible. Also, while it compares the left and right sides of the pituitary, this side-to-side lateralization is imperfect and should not independently determine which part of the gland a surgeon targets [11].
- It requires specialized expertise: IPSS is an invasive procedure that carries uncommon but serious risks, such as bleeding, infection, clotting, contrast-related reactions, and very rarely, neurological complications [12]. It should only be performed at a highly experienced center [13].
What This Means For Your Treatment
A negative MRI does not exclude you from having Cushing disease, nor does it automatically rule out transsphenoidal pituitary surgery [2].
If your biochemical tests and IPSS indicate the pituitary is the source, an expert pituitary surgeon may perform surgery even if the MRI is negative [14]. The surgeon will use the biochemical data, IPSS results, and direct inspection of the gland during the operation to search for and remove the abnormal tissue.
While patients with MRI-negative disease can achieve remission through surgery, finding the tiny tumor is challenging. Remission is not guaranteed, and the lesion may not always be found [14]. If surgery does not lead to remission, or if the tumor cannot be located, your care team will discuss alternative options. These can include medical therapies to control cortisol levels, repeat surgery, radiation, or treatments directed at the adrenal glands.
Common questions in this guide
Does a normal brain MRI rule out Cushing disease?
What tests are used when Cushing disease is suspected but the MRI is normal?
What is IPSS, and why might it be recommended?
Can I have pituitary surgery if my MRI does not show a tumor?
Was my MRI the best type for finding a Cushing disease tumor?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Was my MRI a dedicated 3-Tesla (3T) dynamic pituitary MRI, or a standard brain MRI?
- 2.Could my MRI scans be reviewed by a neuroradiologist who specializes specifically in pituitary tumors?
- 3.Based on my lab results, how confident are you that my condition is ACTH-dependent, and have we adequately evaluated for ectopic sources?
- 4.Do you recommend Inferior Petrosal Sinus Sampling (IPSS) at a specialized center to help confirm if the pituitary is the source?
- 5.If surgery is recommended despite a normal MRI, what are the expected chances of remission, and what alternative medical therapies are available if the tumor is not found?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome.
Senanayake R, Gillett D, MacFarlane J, et al.
Best practice & research. Clinical endocrinology & metabolism 2021; (35(1)):101513 doi:10.1016/j.beem.2021.101513.
PMID: 34045044 - 2
The role of bilateral inferior petrosal sinus sampling in determining the preoperative localization of ACTH-secreting pituitary microadenomas in Cushing's disease: Experience of a tertiary center.
Bestepe N, Ozdemir D, Polat B, et al.
Clinical neurology and neurosurgery 2021; (207()):106724 doi:10.1016/j.clineuro.2021.106724.
PMID: 34102422 - 3
Spurious Plasma Adrenocorticotropic Hormone Level in a Patient With Adrenal Cushing Syndrome.
Chandran S, Goyal A, Mane M, et al.
Ochsner journal 2026; (26(2)):162-166 doi:10.31486/toj.25.0093.
PMID: 42311584 - 4
SELLA TURCICA 3T MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF CUSHING'S DISEASE IN CHILDREN: TWO CASE REPORTS.
Warszawski L, Esteves GSC, Pagnocelli A, et al.
Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo 2019; (37(3)):386-391 doi:10.1590/1984-0462/;2019;37;3;00009.
PMID: 31090849 - 5
Growth Retardation in an Adolescent Secondary to Cushing's Disease Caused by a Pituitary Microadenoma: A Case Report.
Ontoria Betancort MC, García de Pablo I, Díaz Martín C, et al.
Reports (MDPI) 2026; (9(1)) doi:10.3390/reports9010070.
PMID: 41893431 - 6
Pituitary MRI in Cushing's disease - an update.
Bonneville JF, Potorac I, Petrossians P, et al.
Journal of neuroendocrinology 2022; (34(8)):e13123 doi:10.1111/jne.13123.
PMID: 35352410 - 7
Approach to the Patient: Diagnosis of Cushing Syndrome.
Savas M, Mehta S, Agrawal N, et al.
The Journal of clinical endocrinology and metabolism 2022; (107(11)):3162-3174 doi:10.1210/clinem/dgac492.
PMID: 36036941 - 8
Consensus Guidelines on Inferior Petrosal Sinus Sampling: A Guideline From the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.
Siddiq F, Brooks H, Demirtas E, et al.
Stroke (Hoboken, N.J.) 2026; (6(3)):e002309 doi:10.1161/SVIN.125.002309.
PMID: 42088331 - 9
Bilateral inferior petrosal sinus sampling in the diagnosis of ACTH-dependent Cushing's syndrome: experience in a tertiary hospital.
Moreno Parro I, Ortiz Sánchez D, García Moreno R, et al.
Advances in laboratory medicine 2022; (3(3)):282-294 doi:10.1515/almed-2022-0088.
PMID: 37362143 - 10
The Optimal Cut-off of BIPSS in Differential Diagnosis of ACTH-dependent Cushing's Syndrome: Is Stimulation Necessary?
Chen S, Chen K, Wang S, et al.
The Journal of clinical endocrinology and metabolism 2020; (105(4)) doi:10.1210/clinem/dgz194.
PMID: 31758170 - 11
Bilateral inferior petrosal sinus sampling.
Zampetti B, Grossrubatscher E, Dalino Ciaramella P, et al.
Endocrine connections 2016; (5(4)):R12-25 doi:10.1530/EC-16-0029.
PMID: 27352844 - 12
Bilateral inferior petrosal sinus sampling: Procedural data from a German single-center study.
Augustin AM, Detomas M, Hartung V, et al.
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2023; (195(11)):1009-1017 doi:10.1055/a-2083-9942.
PMID: 37224864 - 13
Ectopic Cushing's syndrome from a corticotropin-releasing hormone-secreting medullary thyroid carcinoma: a rare pitfall of inferior petrosal sinus sampling.
Mäkinen VN, Horskær Madsen S, Ji Riis-Vestergaard M, et al.
Endocrinology, diabetes & metabolism case reports 2023; (2023(3)).
PMID: 37767685 - 14
Outcomes of Transsphenoidal Surgery in Cushing Disease Patients with Negative Pituitary Magnetic Resonance Imaging Findings: A Single-Center Experience.
Dai C, Liang S, Liu X, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2020; (26(11)):1320-1330 doi:10.4158/EP-2020-0177.
PMID: 33471663
This page is for informational purposes only and does not constitute medical advice. Your endocrinologist and pituitary specialist should interpret your hormone tests and discuss IPSS or treatment options for your situation.
Get notified when new evidence is published on Cushing disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.